Sponsor Pipeline

Hackensack Meridian Health Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
29
Active Trials
19
Recruiting
2
Phase 3
9
Disease Areas
13
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT05776953
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency…
date change Primary completion pushed: 2026-03-28 -> 2026-09-01
2026-05-23 NCT05776953
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency…
date change Completion pushed: 2026-03-28 -> 2026-09-01
2026-05-23 NCT07442669
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant…
date change Primary completion pushed: 2028-02-28 -> 2028-06-28
2026-05-23 NCT07442669
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant…
date change Completion pushed: 2028-03-05 -> 2028-07-05
2026-05-23 NCT07436754
Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving…
Recruitment opened
2026-05-19 NCT06785402
Ceftriaxone for Post-Treatment Lyme Disease
overall status: "Recruiting" → "Withdrawn"
2026-05-19 NCT06785402
Ceftriaxone for Post-Treatment Lyme Disease
critical why stopped: null → "Enrollment challenges"
2026-05-19 NCT06785402
Ceftriaxone for Post-Treatment Lyme Disease
Enrollment reduced: 20 -> 0 participants
2026-05-19 NCT06785402
Ceftriaxone for Post-Treatment Lyme Disease
date change Primary completion moved earlier: 2027-12-01 -> 2026-05-14
2026-05-19 NCT06785402
Ceftriaxone for Post-Treatment Lyme Disease
date change Completion moved earlier: 2027-12-01 -> 2026-05-14
2026-05-14 NCT06464107
Endometrial Cell Collection With the PadKit
Trial completed
2026-05-14 NCT06464107
Endometrial Cell Collection With the PadKit
date change Primary completion moved earlier: 2026-05-30 -> 2026-04-17
2026-05-14 NCT06464107
Endometrial Cell Collection With the PadKit
date change Completion moved earlier: 2026-05-30 -> 2026-04-17
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-03 NCT07624825 Emotional Awareness Therapy Study Not Yet Recruiting
2026-06-02 NCT07621796 Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent… Phase 3 Not Yet Recruiting
2026-05-19 NCT07594782 ED Medicaid Support Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 2
4
Phase 1/2
3
Phase 1
2
Early Phase 1
2
Not specified
15
Active Trials — top 25 of 29
NCT IDTitleConditionStatus
Phase 4
NCT05776953 Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency… Renal Colic Recruiting
Phase 3
NCT07621796 Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent… Acute Ischemic Stroke Not Yet Recruiting
Phase 2/3
NCT04263025 AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord… Prostate Cancer Active, Not Recruiting
Phase 2
NCT05715229 Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated… Carcinoma, Non-Small-Cell Lung Recruiting
NCT06798558 Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer… Prostate Adenocarcinoma Recruiting
NCT07214688 Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo… Allogeneic Stem Cell Transplant Recipient Recruiting
NCT05726383 Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma Osteogenic Sarcoma Recurrent Recruiting
Phase 1/2
NCT05199311 Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple… Multiple Myeloma Recruiting
NCT03609580 Post-operative Urinary Retention (POUR) Following Thoracic Surgery Urinary Retention Recruiting
NCT01297764 A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or… Multiple Myeloma Active, Not Recruiting
Phase 1
NCT03909412 Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in… Multiple Myeloma Recruiting
NCT02446236 Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory… Mantle Cell Lymphoma Active, Not Recruiting
Early Phase 1
NCT05657990 Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery Urinary Retention Recruiting
NCT07390812 Respiratory Transition Without Continuous Positive Airway Pressure Mild Respiratory Distress Active, Not Recruiting
Not specified
NCT05651945 Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS) Stroke Recruiting
NCT06605534 Leveraging the Emergency Department (LEAD) Study Lung Cancer Recruiting
NCT06937827 Transitions of Care Clinic (TOCC) Heart Failure With Preserved Ejection Fraction Recruiting
NCT06991166 OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression Post Partum Depression Recruiting
NCT06199570 Support for Cancer Patients Awaiting News Lung Cancer Recruiting
NCT07011342 Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment Prostate Cancer Recruiting
NCT07216053 Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm… Pre-Term Recruiting
NCT07436754 Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving… Mild Traumatic Brain Injury Recruiting
NCT06804395 CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer… Cancer Risk Recruiting
NCT04794686 ETMR One: An International Registry and Research Platform for Children With Embryonal… Embryonal Tumor With Multilayered Rosettes Recruiting
NCT06987708 Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on… Monoclonal Gammopathy of Uncertain Significance Not Yet Recruiting
View all 29 active Hackensack Meridian Health trials with filters →
Disease Areas
Get alerts when Hackensack Meridian Health's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free